Counterpoint Mutual Funds LLC Buys 13,417 Shares of Teradyne, Inc. $TER

Counterpoint Mutual Funds LLC increased its stake in shares of Teradyne, Inc. (NASDAQ:TERFree Report) by 520.8% in the first quarter, Holdings Channel.com reports. The firm owned 15,993 shares of the company’s stock after buying an additional 13,417 shares during the quarter. Teradyne comprises approximately 0.7% of Counterpoint Mutual Funds LLC’s investment portfolio, making the stock its 29th biggest position. Counterpoint Mutual Funds LLC’s holdings in Teradyne were worth $4,741,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in TER. State Street Corp grew its stake in shares of Teradyne by 0.9% during the fourth quarter. State Street Corp now owns 7,078,635 shares of the company’s stock worth $1,370,141,000 after buying an additional 60,986 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Teradyne by 6.8% during the third quarter. Ameriprise Financial Inc. now owns 5,256,857 shares of the company’s stock worth $723,600,000 after buying an additional 336,757 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Teradyne by 18.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock valued at $813,640,000 after acquiring an additional 659,273 shares during the last quarter. Invesco Ltd. lifted its stake in shares of Teradyne by 3.5% in the 3rd quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock valued at $407,322,000 after acquiring an additional 99,864 shares during the last quarter. Finally, Alkeon Capital Management LLC boosted its holdings in shares of Teradyne by 48.6% during the 3rd quarter. Alkeon Capital Management LLC now owns 2,872,910 shares of the company’s stock valued at $395,427,000 after acquiring an additional 940,000 shares in the last quarter. Institutional investors own 99.77% of the company’s stock.

Key Headlines Impacting Teradyne

Here are the key news stories impacting Teradyne this week:

Teradyne Stock Performance

Shares of NASDAQ:TER opened at $369.09 on Friday. Teradyne, Inc. has a 52 week low of $88.60 and a 52 week high of $487.91. The firm has a market cap of $57.78 billion, a PE ratio of 68.35, a price-to-earnings-growth ratio of 1.07 and a beta of 1.74. The firm’s fifty day moving average is $386.59 and its 200-day moving average is $316.48.

Teradyne (NASDAQ:TERGet Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.11 by $0.45. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.20 billion. Teradyne had a return on equity of 31.79% and a net margin of 22.55%.Teradyne’s quarterly revenue was up 87.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.75 earnings per share. Sell-side analysts forecast that Teradyne, Inc. will post 7.2 EPS for the current year.

Teradyne Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Thursday, May 21st were given a $0.13 dividend. This is a boost from Teradyne’s previous quarterly dividend of $0.12. The ex-dividend date was Thursday, May 21st. This represents a $0.52 dividend on an annualized basis and a dividend yield of 0.1%. Teradyne’s dividend payout ratio is presently 9.63%.

Insider Activity

In other news, VP Ryan Driscoll sold 680 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $377.60, for a total value of $256,768.00. Following the completion of the sale, the vice president owned 7,665 shares of the company’s stock, valued at approximately $2,894,304. This represents a 8.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shannon John Poulin sold 656 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $355.00, for a total value of $232,880.00. Following the transaction, the insider owned 15,722 shares of the company’s stock, valued at $5,581,310. This trade represents a 4.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 14,941 shares of company stock valued at $5,444,112. Company insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

TER has been the topic of a number of research reports. Citigroup boosted their price objective on Teradyne from $325.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Bank of America increased their target price on Teradyne from $365.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, June 23rd. The Goldman Sachs Group lifted their price target on Teradyne from $300.00 to $350.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Stifel Nicolaus boosted their price target on Teradyne from $325.00 to $390.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Finally, Morgan Stanley set a $387.00 price objective on Teradyne in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $382.87.

Check Out Our Latest Stock Analysis on TER

About Teradyne

(Free Report)

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.

Recommended Stories

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.